{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:30:19Z","timestamp":1773297019409,"version":"3.50.1"},"reference-count":339,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.transci.2005.11.001","type":"journal-article","created":{"date-parts":[[2006,1,11]],"date-time":"2006-01-11T14:36:57Z","timestamp":1136990217000},"page":"51-73","source":"Crossref","is-referenced-by-count":15,"title":["Quo vadis haemapheresis"],"prefix":"10.1016","volume":"34","author":[{"given":"Helmut","family":"Borberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2005.11.001_bib1","first-page":"1516","article-title":"Separation and collection of leukocytes","volume":"25","author":"Freireich","year":"1965","journal-title":"Cancer Res"},{"key":"10.1016\/j.transci.2005.11.001_bib2","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/217816a0","article-title":"Closed continuous flow centrifuge","volume":"217","author":"Judson","year":"1968","journal-title":"Nature"},{"key":"10.1016\/j.transci.2005.11.001_bib3","first-page":"232","article-title":"A simplified centrifuge for the separation and processing of blood cells","volume":"7","author":"Tullis","year":"1967","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2005.11.001_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1537-2995.1973.tb04468.x","article-title":"Efficacy of the Latham blood processor to perform plateletpheresis","volume":"13","author":"Szymanski","year":"1973","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2005.11.001_bib5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/jca.1032","article-title":"A new continuous flow separation method based on cell density: principle, apparatus, and preliminary application to separation of human buffy coat","volume":"16","author":"Ito","year":"2001","journal-title":"J Clin Apher"},{"issue":"6","key":"10.1016\/j.transci.2005.11.001_bib6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0142-9612(85)90102-4","article-title":"Reversibility of granulocyte adhesion using polyamine\u2014grafted nylon\u20146? new column substrate for granulocyte separation","volume":"6","author":"Yui","year":"1985","journal-title":"Biomaterials"},{"issue":"1\u20132","key":"10.1016\/j.transci.2005.11.001_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0378-4347(98)00311-9","article-title":"Surface affinity chromatography of human peripheral blood cells","volume":"722","author":"Shibusawa","year":"1999","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"1\u20133","key":"10.1016\/j.transci.2005.11.001_bib8","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0165-022X(01)00229-9","article-title":"Separation and retention of human blood cells by surface affinity chromatography","volume":"49","author":"Shibusawa","year":"2001","journal-title":"J Biochem Biophys Methods"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1046\/j.1526-0968.1999.00207.x","article-title":"New technique of leukocytapheresis by the use of nonwoven polyester filter for inflammatory bowel disease","volume":"3","author":"Kawamura","year":"1999","journal-title":"Ther Apher"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1526-0968.2001.00358.x","article-title":"Current topics on cytapheresis technologies","volume":"5","author":"Yamayi","year":"2001","journal-title":"Ther Apher"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1526-0968.2002.00419.x","article-title":"Leukocytapheresis using a leukocyte removal filter","volume":"6","author":"Shirokaze","year":"2002","journal-title":"Ther Apher"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jca.2920020108","article-title":"Mononuclear cell collection using various techniques","volume":"2","author":"Dowling","year":"1984","journal-title":"J Clin Apheresis"},{"issue":"1\u20132","key":"10.1016\/j.transci.2005.11.001_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0022-1759(94)90033-7","article-title":"Large scale isolation of human blood monocytes by continuous flow centrifugation leuk apheresis and counterflow centrifugal elutriation for adoptive cellular immunotherapy of cancer patients","volume":"174","author":"Faradji","year":"1994","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.transci.2005.11.001_bib14","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1073\/pnas.93.6.2588","article-title":"CD 14+ blood monocytes can differentiate into functionally mature CD 83+ dendritic cells","volume":"93","author":"Zhou","year":"1996","journal-title":"Proc Natl Acad Sci (USA)"},{"key":"10.1016\/j.transci.2005.11.001_bib15","first-page":"674","article-title":"Extracorporeal photopheresis","volume":"30","author":"Edelson","year":"1984","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"10.1016\/j.transci.2005.11.001_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1473-0502(02)00100-3","article-title":"Extracorporeal photopheresis technical aspects","volume":"28","author":"Schooneman","year":"2003","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0955-3886(94)90178-3","article-title":"Extracorporeal photochemotherapy: evaluation of two techniques and use in connective tissue disorders","volume":"15","author":"Andreu","year":"1994","journal-title":"Transfu Sci"},{"key":"10.1016\/j.transci.2005.11.001_bib18","doi-asserted-by":"crossref","unstructured":"Schreiner T. Small-scale extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma: a report of three cases. In: 14th Congress of the ESfH, Abstract L 14.","DOI":"10.1016\/j.transci.2004.10.020"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jca.2920090310","article-title":"Single-donor platelet concentrates produced along with packed red blood cells with the Haemonetics MCS 3p: preliminary results","volume":"9","author":"Valbonesi","year":"1994","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2005.11.001_bib20","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0278-2391(97)90187-7","article-title":"Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery","volume":"55","author":"Whitman","year":"1997","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.transci.2005.11.001_bib21","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00006534-199804040-00067","article-title":"Platelet gel as an intraoperatively procured platelet based alternative to fibrin glue","volume":"101","author":"Green","year":"1998","journal-title":"Plast Reconst Surg"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0887-7963(96)80085-X","article-title":"Autologous fibrin glue: production and clinical use","volume":"X","author":"Reiss","year":"1996","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.transci.2005.11.001_bib23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1046\/j.1537-2995.2001.41020232.x","article-title":"A novel automated method of temperature cycling to produce cryoprecipitate","volume":"41","author":"Rock","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2005.11.001_bib24","series-title":"Therapeutic plasmapheresis I","first-page":"119","article-title":"Effect of double filtration plasmapheresis on peripheral circulation","author":"Agishi","year":"1981"},{"key":"10.1016\/j.transci.2005.11.001_bib25","first-page":"53","article-title":"A synthetic peptide, Torpedo californica alpha 183\u2013200 of the acetylcholine receptor as a tool for immunoadsorption via plasma perfusion in myasthenia gravis","volume":"1","author":"Takamori","year":"1991","journal-title":"Artif Organs Today"},{"key":"10.1016\/j.transci.2005.11.001_bib26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0022-510X(92)90166-I","article-title":"Myasthenogenicity in the main immunogenic region of acetylcholine receptor as modified by conformational design: an approach to antigenic synthetic peptides","volume":"109","author":"Takamori","year":"1992","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.transci.2005.11.001_bib27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0955-3886(96)00028-8","article-title":"Specific removal of anti-acteylcholine receptor antibodies in patients with myasthenia gravis","volume":"17","author":"Takamori","year":"1996","journal-title":"Transfus Sci"},{"issue":"22","key":"10.1016\/j.transci.2005.11.001_bib28","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1056\/NEJM200211283472220","article-title":"Specific removal of beta 1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy","volume":"347","author":"Wallukat","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1526-0968.2003.00017.x","article-title":"Peptide based adsorbers for therapeutic immunoadsorption","volume":"7","author":"R\u00f6nspeck","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2005.11.001_bib30","unstructured":"Jimenez-Klingberg C. IgG immune apheresis: a newly developed sytem. The young investigators award. In: 4th International congress of the World Apheresis Association, Sapporo, 3\u20135 June 1992."},{"key":"10.1016\/j.transci.2005.11.001_bib31","unstructured":"Borberg H, Jimenez-Klingberg C. Selective adsorption of immunoglobulin G: a comparison of a new type adsorber with protein A and tryptophane conjugated polyvinylalcohol gel columns. In: 4th International congress of the World Apheresis Association, Sapporo, 3\u20135 June 1992, Abstract 111."},{"key":"10.1016\/j.transci.2005.11.001_bib32","first-page":"370","article-title":"Selective adsorption of cryoglobulins from plasma of three patients with mixed type II cryoglobulinemia","volume":"32","author":"Jimenez-Klingberg","year":"1994","journal-title":"Beitr Infusionsther Transfus"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1389-0344(00)00069-1","article-title":"In vitro removal of human IgG autoantibodies by affinity filtration using immobilized l-histidine onto PEVA hollow fiber membranes","volume":"17","author":"Ventura","year":"2001","journal-title":"Biomol Eng"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1744-9987.1998.tb00068.x","article-title":"Therapeutic selective adsorption of anti-DNA antibody using dextran sulfate cellulose column (Selesorb) for the treatment of systemic lupus erythematosus","volume":"2","author":"Kutsuki","year":"1998","journal-title":"Ther Apher"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib35","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1526-0968.2003.00019.x","article-title":"\u00df2-Microglobulin selective adsorber column (Lixelle) for the treatment of dialysis related amyloidosis","volume":"7","author":"Suzuki","year":"2003","journal-title":"Ther Apher Dial"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1526-0968.2003.00018.x","article-title":"Blood purification therapies using dextran sulfate cellulose columns Liposorber and Selesorb","volume":"7","author":"Asahi","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2005.11.001_bib37","unstructured":"Borberg H. Unpublished observations."},{"issue":"9","key":"10.1016\/j.transci.2005.11.001_bib38","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/BF01737944","article-title":"Erythrocytapheresis. A method for rapid extracorporeal elimination of erythrocytes","volume":"66","author":"Zoller","year":"1988","journal-title":"Klin Wschr"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF01648884","article-title":"Treatment of polycythaemia vera by isovolemic large-volume erythrocytapheresis","volume":"68","author":"Kaboth","year":"1990","journal-title":"Klin Wschr"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1744-9987.1997.tb00028.x","article-title":"Advantages of isovolaemic large-volume erythrocytapheresis as a rapidly effective and long- lasting treatment modality for red blood cell depletion of patients with polythemia vera","volume":"1","author":"Kaboth","year":"1997","journal-title":"Ther Apher"},{"issue":"1\u20132","key":"10.1016\/j.transci.2005.11.001_bib41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/(SICI)1098-1101(2000)15:1\/2<28::AID-JCA4>3.0.CO;2-N","article-title":"Therapeutic apheresis in hematological and oncological diseaes","volume":"15","author":"Grima","year":"2000","journal-title":"J Clin Apheresis"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1423-0410.2000.7910040.x","article-title":"Erythrocytapheresis with recombinant human erythropoietin in hereditary haemochromatosis therapy: a new alternative","volume":"79","author":"Kohan","year":"2000","journal-title":"Vox Sang"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0955-3886(00)00042-4","article-title":"Clinical application of therapeutic erythrocytapheresis (TEA)","volume":"22","author":"Valbonesi","year":"2000","journal-title":"Transfus Sci"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jca.10024","article-title":"In hereditary haemochromatosis, red cell apheresis removes excess iron twice as fast as manual whole blood phlebototmy","volume":"17","author":"Muncunill","year":"2002","journal-title":"J Clin Apheresis"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib45","first-page":"194","article-title":"Phenotypes and spontaneous immunoglobulin production in mononuclear cells suspensions isolated from colonic biopsies of patients with mild active and quiescent ulcerative colitis","volume":"15","author":"Squarcia","year":"1991","journal-title":"Gastroenterol Clin Biol"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib46","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2249.1994.tb06047.x","article-title":"Il-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn\u2019s disease","volume":"96","author":"Mitsuyama","year":"1994","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"10.1016\/j.transci.2005.11.001_bib47","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1111\/j.1572-0241.2002.07029.x","article-title":"Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis","volume":"97","author":"Tsukada","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1744-9987.1998.tb00082.x","article-title":"Granulocyte apheresis in inflammatory bowel disease: possible mechanism of effect","volume":"2","author":"Rembacken","year":"1998","journal-title":"Ther Apher"},{"issue":"7","key":"10.1016\/j.transci.2005.11.001_bib49","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/00042737-200107000-00013","article-title":"Characterization of antigen presenting dendritic cells in the peripheral blood and colonic mucosa of patients with ulcerative colitis","volume":"13","author":"Ikeda","year":"2001","journal-title":"Eur J Gastroenterlol Hepatol"},{"issue":"Suppl 14","key":"10.1016\/j.transci.2005.11.001_bib50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF03326414","article-title":"Antigen presenting dendritic cells in ulcerative colitis","volume":"37","author":"Ikeda","year":"2002","journal-title":"J Gastroenterol"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib51","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10350-004-6593-2","article-title":"Depletion and decreased function of antigen\u2014presenting dendritic cells caused by lymphocytapheresis in ulcerative colitis","volume":"46","author":"Ikeda","year":"2003","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib52","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1744-9987.1998.tb00089.x","article-title":"Centrifugal leukocytapheresis for ulcerative colitis","volume":"2","author":"Ayabe","year":"1998","journal-title":"Ther Apher"},{"issue":"6","key":"10.1016\/j.transci.2005.11.001_bib53","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1046\/j.1526-0968.2001.00379.x","article-title":"Effective maintenance leukocytapheresis for patients with steroid dependent or resistant ulcerative colitis","volume":"5","author":"Kondo","year":"2001","journal-title":"Ther Apher"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jca.1000","article-title":"Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study","volume":"16","author":"Shimoyama","year":"2001","journal-title":"J Clin Apheresis"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib55","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1526-0968.2002.00441.x","article-title":"Leukocyte apheresis using a centrifugal cell separator in refractory ulcerative colitis: a multicenter open label trial","volume":"6","author":"Kohgo","year":"2002","journal-title":"Ther Apher"},{"issue":"Suppl 15","key":"10.1016\/j.transci.2005.11.001_bib56","first-page":"51","article-title":"Leukocytapheresis for treatment of IBD","volume":"38","author":"Kohgo","year":"2003","journal-title":"J Gastroenterol"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib57","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/00000441-200305000-00009","article-title":"Granulocyte and monocyte adsorption apheresis in a patient with antiglomerular basement membrane glomerulonephritis and active ulcerative colitis","volume":"325","author":"Nakamura","year":"2003","journal-title":"Am J Med Sci"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib58","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1381612033391928","article-title":"Multicenter randomized controlled trial from the treatment of ulcerative colitis with a leukocytapheresis column","volume":"9","author":"Sawada","year":"2003","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib59","first-page":"511","article-title":"Granulocytapheresis for Crohn\u2019s disease: a report of seven refractory patients","volume":"98","author":"Matsui","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.transci.2005.11.001_bib60","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/jca.2920100406","article-title":"Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infections","volume":"10","author":"Hester","year":"1995","journal-title":"J Clin Apher"},{"issue":"Suppl 2","key":"10.1016\/j.transci.2005.11.001_bib61","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF03165092","article-title":"Granulocyte transfusion in the G-CSF era","volume":"76","author":"Price","year":"2002","journal-title":"Int J Hematol"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib62","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.0042-9007.2003.00373.x","article-title":"Tolerance of granulocyte donors towards granulocyte colony-stimulating factor stimulation and of patients towards granulocyte transfusions: results of a multicentre study","volume":"85","author":"Bux","year":"2003","journal-title":"Vox Sang"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib63","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1365-3148.2003.00451.x","article-title":"Granulocyte concentrates: how can we assess their quality?","volume":"13","author":"Bashir","year":"2003","journal-title":"Transfus Med"},{"issue":"6","key":"10.1016\/j.transci.2005.11.001_bib64","first-page":"522","article-title":"Granulocyte transfusion revisited","volume":"2","author":"Briones","year":"2003","journal-title":"Curr Hematol Rep"},{"key":"10.1016\/j.transci.2005.11.001_bib65","series-title":"Klinische Onkologie","first-page":"20.20","article-title":"Zellul\u00e4re Substitution","author":"Borberg","year":"1985"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib66","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00520-002-0394-8","article-title":"Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases","volume":"11","author":"Cesaro","year":"2003","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib67","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/14653240310000047","article-title":"Efficacy of granulocyte transfusions for neutropenia-related infections: retrospective analysis of predictive factors","volume":"5","author":"Rutella","year":"2003","journal-title":"Cytotherapy"},{"key":"10.1016\/j.transci.2005.11.001_bib68","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s15010-002-2133-y","article-title":"Efficacy and safety of G-CSF mobilized granulocyte transfusions in four neutropenic children with sepsis and invasive fungal infection","volume":"30","author":"Grigull","year":"2003","journal-title":"Infection"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib69","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00277-002-0439-6","article-title":"Treatment and prophylaxis of severe infections in neutropenic patients by granulocyte transfusions","volume":"81","author":"Illerhaus","year":"2002","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib70","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.bmt.1703780","article-title":"Granulocyte transfusion as a treatment for enterococcal meningoencephalitis after allogeneic bone marrow transplantation from an unrelated donor","volume":"31","author":"Tsukada","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib71","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood-2002-07-2110","article-title":"Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation","volume":"101","author":"Vij","year":"2003","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.transci.2005.11.001_bib72","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood.V99.9.3483","article-title":"Cytomegalovirus infections in cancer patients receiving granulocyte transfusions","volume":"99","author":"Nichols","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib73","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0952-7915(97)80153-7","article-title":"Origin, maturation and antigen presenting function of dendritic cells","volume":"9","author":"Cella","year":"1997","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib74","first-page":"187","article-title":"In vitro generation of human dendritic cells and cell therapy","volume":"3","author":"Gluckman","year":"1997","journal-title":"Cytokines Cell Mol Ther"},{"issue":"9","key":"10.1016\/j.transci.2005.11.001_bib75","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0167-5699(00)01694-7","article-title":"Dendritic cells: multi-lineal and multi-functional","volume":"21","author":"Grabbe","year":"2000","journal-title":"Immunol Today"},{"issue":"12","key":"10.1016\/j.transci.2005.11.001_bib76","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S1471-4906(01)02059-2","article-title":"Origin and differentiation of dendritic cells","volume":"22","author":"Ardavin","year":"2001","journal-title":"Trends Immunol"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib77","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0171-2985(98)80074-0","article-title":"Comparative analysis of dendritic cells derived from blood monocates or CD 34+ haematopoietic progenitor cells","volume":"198","author":"Meierhoff","year":"1998","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib78","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ni0104-7","article-title":"Dendritic cells: A journey from laboratory to clinic","volume":"5","author":"Cerundolo","year":"2004","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib79","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4049\/jimmunol.162.1.168","article-title":"Generation of tumour immunity by bone marrow derived dendritic cells correlates with dendritic cell maturation","volume":"162","author":"Labeur","year":"1999","journal-title":"J Immunol"},{"issue":"1\u20133","key":"10.1016\/j.transci.2005.11.001_bib80","first-page":"133","article-title":"Dendritic cells in cancer immunotherapy","volume":"21","author":"Gunzer","year":"2001","journal-title":"Crit Rev Immunol"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib81","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/smim.2001.0325","article-title":"Dendritic cells and tumor immunity","volume":"13","author":"Gunzer","year":"2001","journal-title":"Semin Immunol"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib82","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00002371-200305000-00009","article-title":"Generation of melanoma-specific cytotoxic T lymphocytes for allogeneic immunotherapy","volume":"26","author":"Nolte","year":"2003","journal-title":"J Immunother"},{"key":"10.1016\/j.transci.2005.11.001_bib83","unstructured":"Sorg R, Brefort Th, Fischer J, Ackermann R, Wernet P. Clinical scale generation of dendritic cells in a closed system. In: 7th International symposium on dendritic cells, Bamberg, Germany, 19\u201324 September 2002. p. 186."},{"key":"10.1016\/j.transci.2005.11.001_bib84","unstructured":"Chui SY, Clay TM, Hobeika AC, Venturi CB, Osada T, Khan S, et al. Dendritic cell vaccination following high dose chemotherapy with autologous stem cell support for breast cancer: long term follow up ASCO, 2003. Abstract no. 682."},{"key":"10.1016\/j.transci.2005.11.001_bib85","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1470-2045(00)00153-4","article-title":"Haemopoietic stem-cell transplantation: recent progress and future","volume":"1","author":"Craddock","year":"2000","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib86","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1040-8428(00)00087-1","article-title":"Overview of autologous stem cell transplantation","volume":"36","author":"Saba","year":"2000","journal-title":"Crit Rev Oncol Hematol"},{"issue":"8","key":"10.1016\/j.transci.2005.11.001_bib87","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/sj.bmt.1703535","article-title":"Allogeneic and autologous transplantation for haematological diseases, solid tumors, and immune disorders: definitions and current practice in Europe","volume":"29","author":"Urbano-Ispizua","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib88","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1526-0968.2002.00392.x","article-title":"Peripheral blood progenitor cell transplantation","volume":"6","author":"Jansen","year":"2002","journal-title":"Ther Apher"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib89","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1468-0734.2001.00033.x","article-title":"Allogeneic peripheral blood stem cell transplantation","volume":"5","author":"Bensinger","year":"2001","journal-title":"Rev Clin Exp Haematol"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib90","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00001622-200203000-00003","article-title":"Autologous stem cell transplantation for adult acute leukaemia","volume":"14","author":"Gorin","year":"2002","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.transci.2005.11.001_bib91","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMra022361","article-title":"Adult stem cells for tissue repair\u2014a new therapeutic concept","volume":"349","author":"K\u00f6rbling","year":"2003","journal-title":"N Engl J Med"},{"issue":"5356","key":"10.1016\/j.transci.2005.11.001_bib92","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1126\/science.279.5356.1528","article-title":"Muscle regeneration by bone marrow derived mogenic progenitors","volume":"279","author":"Ferrari","year":"1998","journal-title":"Science"},{"issue":"Suppl 1","key":"10.1016\/j.transci.2005.11.001_bib93","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0960-8966(02)00102-5","article-title":"Myogenic stem cells from the bone marrow: a therapeutic alternative for muscular dystrophy?","volume":"12","author":"Ferrari","year":"2002","journal-title":"Neuromusc Disord"},{"key":"10.1016\/j.transci.2005.11.001_bib94","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/excr.1997.3858","article-title":"In vitro chondrogenesis of bone marrow derived mesenchymal progenitor cells","volume":"238","author":"Johnstone","year":"1998","journal-title":"Exp Cell Res"},{"issue":"11","key":"10.1016\/j.transci.2005.11.001_bib95","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/81326","article-title":"Purified hematopoietic stem cells can differentiate into hepatocytes in vivo","volume":"6","author":"Lagasse","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.transci.2005.11.001_bib96","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJMoa3461002","article-title":"Hepatocytes and epithelial cells of donor origin in recipients of peripheral blood stem cells","volume":"346","author":"K\u00f6rbling","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2005.11.001_bib97","doi-asserted-by":"crossref","first-page":"10344","DOI":"10.1073\/pnas.181177898","article-title":"Mobilized bone marrow cells repair the infarcted heart, improving function and survival","volume":"98","author":"Orlic","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.transci.2005.11.001_bib98","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/35070587","article-title":"Bone marrow cells regenerate infarcted myocardium","volume":"410","author":"Orlic","year":"2001","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.transci.2005.11.001_bib99","first-page":"1219","article-title":"Cell transplantation for post ischaemic-heart failure","volume":"95","author":"Vilquin","year":"2002","journal-title":"Arch Mal Coeur Vaiss"},{"key":"10.1016\/j.transci.2005.11.001_bib100","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1161\/01.CIR.0000034046.87607.1C","article-title":"Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans","volume":"106","author":"Strauer","year":"2002","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.transci.2005.11.001_bib101","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1681\/ASN.V1271401","article-title":"The potential of bone marrow derived cells to differentiate to glomerular mesangial cells","volume":"12","author":"Imasawa","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2005.11.001_bib102","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1681\/ASN.V12122625","article-title":"Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling","volume":"12","author":"Ito","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2005.11.001_bib103","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1172\/JCI17856","article-title":"Bone marrow stem cells contribute to the repair of the ischemically injured renal tube","volume":"112","author":"Kale","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.transci.2005.11.001_bib104","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/01.STR.32.4.1005","article-title":"Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats","volume":"32","author":"Chen","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.transci.2005.11.001_bib105","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1083\/jcb.200105103","article-title":"Neogenesis of cerebellar Purkinje neurons from gene-marked bone marrow cells in vivo","volume":"155","author":"Priller","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.transci.2005.11.001_bib106","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1242\/dev.128.24.5181","article-title":"Bone marrow derived cells as progenitors of lung alveolar epithelium","volume":"128","author":"Kotton","year":"2002","journal-title":"Development"},{"key":"10.1016\/j.transci.2005.11.001_bib107","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1634\/stemcells.20-4-279","article-title":"Bone marrow derived stem cells can differentiate into retinal cells in injured rat retina","volume":"20","author":"Tomita","year":"2002","journal-title":"Stem Cells"},{"key":"10.1016\/j.transci.2005.11.001_bib108","doi-asserted-by":"crossref","first-page":"7742","DOI":"10.1523\/JNEUROSCI.23-21-07742.2003","article-title":"Differentiation of marrow stroma cells into photoreceptors in the rat eye","volume":"23","author":"Kicic","year":"2003","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib109","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for x-linked severe combined immunodeficiency by ex vivo gene therapy","volume":"348","author":"Hacein-Bay-Abina","year":"2003","journal-title":"N Engl J Med"},{"issue":"6917","key":"10.1016\/j.transci.2005.11.001_bib110","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/420735b","article-title":"Gene therapy: shining hopes dented\u2014but not dashed","volume":"420","author":"Check","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.transci.2005.11.001_bib111","first-page":"113","article-title":"Zur Immuntherapie von Tumoren: Die adoptive Immunisierung als Mittel der Wachs tumshemmung und R\u00fcckbildung transplantierter Fibrosarkome der Maus","volume":"76","author":"Borberg","year":"1970","journal-title":"Verhdl Deutsch Ges Inn Med"},{"key":"10.1016\/j.transci.2005.11.001_bib112","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ijc.2910100312","article-title":"Inhibition of established transplants of chemically induced sarcomas in syngeneic mice by lymphocytes from immunized donors","volume":"10","author":"Borberg","year":"1972","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib113","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0268-960X(99)90023-1","article-title":"Dendritic cells: development, function, and potential use for cancer","volume":"13","author":"Avigan","year":"1999","journal-title":"Blood Rev"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib114","first-page":"72","article-title":"The use of dendritic cells for cancer vaccination","volume":"1","author":"Esche","year":"1999","journal-title":"Curr Opin Mol Ther"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib115","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4049\/jimmunol.162.1.168","article-title":"Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage","volume":"162","author":"Labeur","year":"1999","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib116","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1006681312249","article-title":"Active immunization of humans with dendritic cells","volume":"20","author":"Dhodapkar","year":"2000","journal-title":"J Clin Immunol"},{"issue":"9","key":"10.1016\/j.transci.2005.11.001_bib117","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00432-003-0462-6","article-title":"Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation of recombinant protein-pulsed dendritic cells induces specific T cell to HPV16E7 or HPV18E\/7","volume":"129","author":"Nonn","year":"2003","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"10.1016\/j.transci.2005.11.001_bib118","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00432-003-0463-5","article-title":"Dendritic cell based-tumor vaccine for cervival cancer II: results of a clinical pilot study in 15 individual patients","volume":"129","author":"Ferrara","year":"2003","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.transci.2005.11.001_bib119","unstructured":"Chui SY, Clay TM, Hobeika AC, Venturi CB, Osada T, Khan S, et al. Dendritic cell vaccination following high dose chemotherapy with autologous stem cell support for breast cancer: long term follow up. In: Proceedings, ASCO 2003. Abstract no. 682."},{"issue":"Suppl 1","key":"10.1016\/j.transci.2005.11.001_bib120","first-page":"22","article-title":"Dendritic cell based immunotherapy in patients with hormone resistant prostata carcinoma in combination with interferon gamma","volume":"26","author":"Weber","year":"2003","journal-title":"Onkologie"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib121","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s109-1998-8102-9","article-title":"The molecular basis of cancer immunotherapy by cytotoxic T lymphocytes","volume":"76","author":"Lindauer","year":"1998","journal-title":"J Mol Med"},{"issue":"1\u20132","key":"10.1016\/j.transci.2005.11.001_bib122","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1615\/CritRevImmunol.v18.i1-2.60","article-title":"Strategies for tumor elimination by cytotoxic T lymphocytes","volume":"18","author":"Sherman","year":"1998","journal-title":"Crit Rev Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.transci.2005.11.001_bib123","first-page":"20","article-title":"Adoptive T cell transfer","volume":"26","author":"Thomas","year":"2003","journal-title":"Onkologie"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib124","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1182\/blood-2002-01-0131","article-title":"Autologous stem cell transplantation followed by a dose reduced allograft induces high complete remission rate in multiple myeloma","volume":"100","author":"Kr\u00f6ger","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/1042819021000050061","article-title":"Donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukaemia","volume":"44","author":"Gilleece","year":"2003","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib126","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S1083-8791(03)00077-6","article-title":"Impact of prophylactic donor leukocyte infusion on mixed chimerism, graft versus host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation","volume":"9","author":"Dey","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"14","key":"10.1016\/j.transci.2005.11.001_bib127","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1200\/JCO.2003.12.011","article-title":"Evidence of graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the cooperative German Transplant Study Group","volume":"21","author":"Schetelig","year":"2003","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib128","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1526-0968.2003.00056.x","article-title":"A clinical role for peripheral blood lymphocyte infusions and perspectives on collection","volume":"7","author":"Hester","year":"2003","journal-title":"Ther Apher Dial"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF02983795","article-title":"Graft-versus-host disease, the graft-versus-leukemia effect and mixed chimerism follo wing nonmyeloablative stem cell transplantation","volume":"78","author":"Slavin","year":"2003","journal-title":"Int J Hematol"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib130","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.bmt.1704150","article-title":"Allogeneic cell\u2014mediated immunotherapy of leukemia with immune donor lymphocytes to upregulate antitumor effects and downregulate antihost responses","volume":"32","author":"Ji","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.transci.2005.11.001_bib131","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/01.TP.0000085285.59061.D7","article-title":"Donor lymphocyte infusion for late relapse followed by kidney transplantation for end- stage renal failure after allogeneic bone marrow transplantation for chronic myeloid leukemia","volume":"76","author":"Humblet-Baron","year":"2003","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.transci.2005.11.001_bib132","first-page":"865","article-title":"Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors","author":"Nortier","year":"2003","journal-title":"Exp Hematol"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib133","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/sj.bmt.1704107","article-title":"Use of a reduced-intensity conditioning regimen for allogeneic transplantation in patients with chronic myeloid leukemia","volume":"32","author":"Das","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib134","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1040-8428(02)00108-7","article-title":"Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man","volume":"46","author":"Slavin","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"issue":"8","key":"10.1016\/j.transci.2005.11.001_bib135","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2003.09.110","article-title":"Allogeneic stem-cell transplantation from related and unrelated donors in older patients with myeloid leukemia","volume":"21","author":"Bertz","year":"2003","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.transci.2005.11.001_bib136","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.bmt.1703883","article-title":"Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions","volume":"31","author":"Raiola","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib137","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.bmt.1703779","article-title":"Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study","volume":"31","author":"Lewalle","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib138","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.bmt.1703803","article-title":"Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft","volume":"31","author":"Lee","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib139","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1182\/blood-2003-07-2559","article-title":"Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens","volume":"103","author":"Bellucci","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib140","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood-2003-07-2344","article-title":"Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hemato poietic cell transplantation following nonmyeloablative conditioning","volume":"103","author":"Bethge","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.transci.2005.11.001_bib141","first-page":"579","article-title":"Molecular aspects of extracorporeal photochemotherapy","volume":"62","author":"Gasparro","year":"1989","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.transci.2005.11.001_bib142","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1749-6632.1991.tb33446.x","article-title":"Photopheresis: a clinically relevant immunobiologic response modifier","volume":"636","author":"Edelson","year":"1991","journal-title":"Ann NY Acad Sci"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib143","first-page":"62","article-title":"Cutanous T-cell lymphoma. A model for selective immunotherapy","volume":"4","author":"Edelson","year":"1998","journal-title":"Cancer J Sci Am"},{"key":"10.1016\/j.transci.2005.11.001_bib144","first-page":"25","article-title":"Photopheresis for T-cell mediated diseases","volume":"3","author":"Heald","year":"1988","journal-title":"Adv Dermatol"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib145","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/jca.2920100309","article-title":"T-cell responses in photoimmune therapy","volume":"10","author":"Heald","year":"1995","journal-title":"J Clin Apher"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib146","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1473-0502(03)00103-4","article-title":"Mechanisms of action of extracorporeal photochemotherapy","volume":"29","author":"Heshmati","year":"2003","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib147","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-0502(02)00011-3","article-title":"Transimmunization and the evolution of extracorporeal photochemotherapy","volume":"26","author":"Girardi","year":"2002","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib148","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jca.2920090108","article-title":"Role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection","volume":"9","author":"Rook","year":"1994","journal-title":"J Clin Apheresis"},{"issue":"12","key":"10.1016\/j.transci.2005.11.001_bib149","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1525-1594.1994.tb03340.x","article-title":"Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection","volume":"18","author":"Wolfe","year":"1994","journal-title":"Artif Organs"},{"key":"10.1016\/j.transci.2005.11.001_bib150","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM198702053160603","article-title":"Treatment of cutaneous T cell lymphoma by extracorporeal photochemotherapy. Preliminary results","volume":"316","author":"Edelson","year":"1987","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib151","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1001\/archderm.135.5.600","article-title":"Sezary syndrome, cutaneous T-cell lymphoma and extracorporeal photopheresis","volume":"135","author":"Edelson","year":"1999","journal-title":"Arch Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.transci.2005.11.001_bib152","first-page":"16","article-title":"Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis","volume":"107","author":"Rook","year":"1997","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"10.1016\/j.transci.2005.11.001_bib153","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/archderm.138.8.1054","article-title":"Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution","volume":"138","author":"Suchin","year":"2002","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.transci.2005.11.001_bib154","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0190-9622(96)90119-X","article-title":"Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution","volume":"35","author":"Gottlieb","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.transci.2005.11.001_bib155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-0502(02)00098-8","article-title":"Follow-up of the T-cell clonality in Sezary patients treated by extracorporeal photopheresis using a new assay: the immunoscope technique","volume":"28","author":"Ingen-Housz-Oro","year":"2003","journal-title":"Transfus Apher Sci"},{"issue":"Suppl 5","key":"10.1016\/j.transci.2005.11.001_bib156","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/039139889301605s36","article-title":"Application of extracorporeal photochemotherapy in \u201cnon-oncological\u201d diseases","volume":"16","author":"Dall\u2019Amico","year":"1993","journal-title":"Int J Artif Organs"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib157","first-page":"845","article-title":"Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis","volume":"14","author":"Owsianowski","year":"1994","journal-title":"Bone M Transpl"},{"issue":"Suppl 2","key":"10.1016\/j.transci.2005.11.001_bib158","first-page":"175","article-title":"Extracorporeal photochemotherapy for the treatment of graft-versus-host disease","volume":"18","author":"Rosseti","year":"1996","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib159","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1744-9987.1997.tb00025.x","article-title":"Extracorporeal photochemotherapy: a treatment for organ graft rejection","volume":"1","author":"Heshmati","year":"1997","journal-title":"Ther Apher"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1473-0502(02)00097-6","article-title":"Extracorporeal photochemotherapy: a historical perspective","volume":"28","author":"Heshmati","year":"2003","journal-title":"Transfus Apher Sci"},{"issue":"7","key":"10.1016\/j.transci.2005.11.001_bib161","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1182\/blood.V96.7.2426","article-title":"Extracorporeal photochemotherapy in the treatment of severe steroid-refractory graft-versus-host disease: a pilot study","volume":"96","author":"Greinix","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib162","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/(SICI)1098-1101(1996)11:1<36::AID-JCA8>3.0.CO;2-C","article-title":"Reversal of acute renal allograft rejection by extracorporeal photopheresis: a case presentation and review of the literature","volume":"11","author":"Wolfe","year":"1996","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.transci.2005.11.001_bib163","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/00007890-199204000-00021","article-title":"Successfull treatment of heart transplant rejection with photopheresis","volume":"53","author":"Constano-Nordin","year":"1992","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib164","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00007890-199402000-00015","article-title":"Reduction of the incidence of rejection by adjunct immunosuppression with photochemotherapy after heart transplantation","volume":"57","author":"Meiser","year":"1994","journal-title":"Transplantation"},{"issue":"24","key":"10.1016\/j.transci.2005.11.001_bib165","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJM199812103392404","article-title":"Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis transplantation study group","volume":"339","author":"Barr","year":"1998","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib166","first-page":"793","article-title":"Extracorporeal photochemotherapy treatment for acute lung rejection episode","volume":"14","author":"Andreu","year":"1995","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib167","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00005176-200310000-00022","article-title":"Photopheresis treatment in severe Crohn\u2019s disease","volume":"37","author":"Guariso","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.transci.2005.11.001_bib168","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1749-6632.1991.tb33442.x","article-title":"Antigen specific tolerance induced by autoimmunization with photoinactiveted syngeneic effector cells","volume":"636","author":"Laroche","year":"1991","journal-title":"Ann NY Acad Sci"},{"issue":"Suppl 1","key":"10.1016\/j.transci.2005.11.001_bib169","first-page":"52","article-title":"Ultraviolet light induced immunomodulation: a possible new tool in organ transplantation","volume":"143","author":"Andreu","year":"1992","journal-title":"Ann Med Intern (Paris)"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib170","doi-asserted-by":"crossref","first-page":"303","DOI":"10.7326\/0003-4819-112-4-303","article-title":"Extracorporeal photochemotherapy for drug resistant pemphigus vulgaris","volume":"112","author":"Rook","year":"1990","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib171","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/art.1780350311","article-title":"Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A Pilot study","volume":"35","author":"Knobler","year":"1992","journal-title":"Arthritis Rheum"},{"issue":"2\u20133","key":"10.1016\/j.transci.2005.11.001_bib172","first-page":"323","article-title":"Extracorporeal photochemotherapy for the treatment of lupus erythematosus: preliminary observations","volume":"16","author":"Knobler","year":"1994","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.transci.2005.11.001_bib173","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1749-6632.1991.tb33453.x","article-title":"Photopheresis for rheumatoid arthritis","volume":"636","author":"Malawista","year":"1991","journal-title":"Ann NY Acad Sci"},{"issue":"6","key":"10.1016\/j.transci.2005.11.001_bib174","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/art.1780340604","article-title":"Treatment of rheumatoid arthritis by extracorporeal photochemotherapy. A pilot study","volume":"34","author":"Malawista","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib175","first-page":"125","article-title":"Treatment of refractory rheumathoid polyarthritis by extracorporeal photochemotherapy","volume":"60","author":"Hilliquin","year":"1993","journal-title":"Rev Rhum Ed Fr"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib176","first-page":"406","article-title":"Photochemotherapy for refractory rheumatoid arthritis","volume":"23","author":"Hillequin","year":"1996","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib177","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1067\/mjd.2003.11","article-title":"Sezary syndrome and seronegative polyarthritis: treatment with extracorporeal photochemotherapy","volume":"48","author":"Macheiner","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.transci.2005.11.001_bib178","series-title":"Therapeutic Plasmapheresis I","first-page":"119","article-title":"Effect of double filtration plasmapheresis on peripheral circulation","author":"Agishi","year":"1981"},{"key":"10.1016\/j.transci.2005.11.001_bib179","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0955-3886(00)00126-0","article-title":"The current state of extracorporeal haemorheotherapy: from haemodilution via cascade filtration to rheohaemapheresis","volume":"24","author":"Borberg","year":"2001","journal-title":"Transf Apher Sci"},{"key":"10.1016\/j.transci.2005.11.001_bib180","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1473-0502(01)00006-4","article-title":"First experience with a ready-for-use rheohaemapheresis system","volume":"24","author":"Schreiner","year":"2001","journal-title":"Transf Apher Sci"},{"key":"10.1016\/j.transci.2005.11.001_bib181","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2362.1989.tb00192.x","article-title":"Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin induced extracorporeal LDL precipitation","volume":"19","author":"Schuff-Werner","year":"1988","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.transci.2005.11.001_bib182","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000014308","article-title":"Changes of haemorheological and biochemical parameters after plasma perfusion using a tryptophane\u2013polyvinylalcohol adsorber leading to clinical improvement in patients suffering from maculopathy","volume":"16","author":"Widder","year":"1998","journal-title":"Blood Purificat"},{"issue":"6","key":"10.1016\/j.transci.2005.11.001_bib183","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1053\/meta.2000.6264","article-title":"Contribution of fibrinogen and lipoproteins to plasma viscosity in hypercholesterolemia and hypertriglyceridemia: evaluation by selective depletion of low-density lipoproteins or fibrinogen","volume":"49","author":"Otto","year":"2000","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib184","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1526-0968.2001.00335.x","article-title":"Fibrinogen adsorption in the diabetic foot syndrome and peripheral arterial occlusive disease: first clinical experience","volume":"5","author":"Richter","year":"2001","journal-title":"Ther Apher"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib185","first-page":"483","article-title":"Influence of membrane differential filtration on the natural course of age-related macular degeneration. A randomised trial","volume":"20","author":"Brunner","year":"2000","journal-title":"Retina"},{"key":"10.1016\/j.transci.2005.11.001_bib186","first-page":"85","article-title":"Multicenter prospective, randomised, double-masked, placebo-controlled study of rheopheresis to treat nonexudative age-related macular degeneration: interim analysis","volume":"100","author":"Pulido","year":"2002","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.transci.2005.11.001_bib187","unstructured":"Widder RA, Farvili E, Reis RGJ, L\u00fcke C, Walter P, Kirchhof B, et al. The Treatment of age-related macular degeneration (ARMD) with extracorporeal treatment procedures. A follow-up of four years. In: Annual meeting of the Association for Research in Vision and Ophthalmology (ARVO), 2002, A 2906."},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib188","first-page":"35","article-title":"Extracorporeal hemorheotherapy of refractory angina pectoris","volume":"16","author":"Tauchert","year":"1997","journal-title":"Jpn J Apheresis"},{"issue":"7","key":"10.1016\/j.transci.2005.11.001_bib189","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1080\/00016489950180397","article-title":"Clinical utility of LDL-elimination in the treatment of sudden hearing loss: a prospective randomised study","volume":"119","author":"Suckf\u00fcll","year":"1999","journal-title":"Acta Otolaryngol"},{"issue":"9348","key":"10.1016\/j.transci.2005.11.001_bib190","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(02)11768-5","article-title":"Fibrinogen and LDL-apheresis in treatment of sudden hearing loss: a randomized multicentre trial","volume":"360","author":"Suckf\u00fcll","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2005.11.001_bib191","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jca.1004","article-title":"Improvement of macualar function in diabetic retinopathy","volume":"16","author":"L\u00fcke","year":"2001","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2005.11.001_bib192","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0955-3886(00)00126-0","article-title":"The current state of extracorporeal haemorheotherapy: From haemodilution via cascade filtration to rheohaemapheresis","volume":"24","author":"Borberg","year":"2001","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib193","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1526-0968.2001.005002128.x","article-title":"The role of rheology in hemapheresis","volume":"5","author":"Borberg","year":"2001","journal-title":"Ther Apher"},{"key":"10.1016\/j.transci.2005.11.001_bib194","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0955-3886(96)00046-X","article-title":"Clinical efficacy of haemorheological treatment using plasma exchange, selective adsorption and cascade filtration in maculopathy, retinal vein occlusion and uveal effusion syndrome","volume":"17","author":"Brunner","year":"1997","journal-title":"Transfus Sci"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib195","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0955-3886(96)00028-8","article-title":"Specific removal of anti-acetylcholine receptor antibodies in patients with myasthenia gravis","volume":"17","author":"Takamori","year":"1996","journal-title":"Transfus Sci"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib196","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1046\/j.1526-0968.2001.00367.x","article-title":"Immunoadsorption in myasthenia gravis based on specific ligands mimicking the immunogenic sites of the acetylcholine receptor","volume":"5","author":"Takamori","year":"2001","journal-title":"Ther Apher"},{"issue":"22","key":"10.1016\/j.transci.2005.11.001_bib197","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1056\/NEJM200211283472220","article-title":"Specific removal of beta 1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy","volume":"347","author":"Wallukat","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib198","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0167-5273(96)02598-3","article-title":"Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption","volume":"54","author":"Wallukat","year":"1996","journal-title":"Int J Cardiol"},{"issue":"8","key":"10.1016\/j.transci.2005.11.001_bib199","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1161\/01.CIR.95.8.1994","article-title":"Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy","volume":"95","author":"Dorffel","year":"1997","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib200","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1526-0968.2000.00177.x","article-title":"Immunoadsorption in dilated cardiomyopathy","volume":"4","author":"Dorffel","year":"2000","journal-title":"Ther Apher"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib201","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.CIR.101.4.385","article-title":"Immunoglobulin adsorption in patients with idiopathic dilatative cardiomyopathy","volume":"101","author":"M\u00fcller","year":"2000","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib202","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1358\/mf.2001.23.3.627947","article-title":"Acute hemodynamic effects during immunoadsorption in patients with dilated cardiomyopathy positive for beta 1-adrenoreceptor autoantibodies","volume":"23","author":"Christ","year":"2001","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib203","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0735-1097(01)01794-6","article-title":"Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption","volume":"39","author":"Felix","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.transci.2005.11.001_bib204","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/hc3401.095198","article-title":"Advances in the understanding of myocarditis","volume":"104","author":"Liu","year":"2001","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib205","first-page":"327","article-title":"Progress in understanding humoral rejection in kidney transplantation: implication for patient management","volume":"21","author":"Pascual","year":"2001","journal-title":"Nefrologia"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib206","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/S0041-1345(02)03044-0","article-title":"Preemptive therapy with plasmapheresis\/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match","volume":"34","author":"Sonnenday","year":"2002","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib207","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1526-0968.2000.004005395.x","article-title":"Removal of anti-A\/B antibodies with plasmapheresis in ABO-incompatible kidney transplantation","volume":"4","author":"Shimmura","year":"2000","journal-title":"Ther Apher"},{"issue":"6","key":"10.1016\/j.transci.2005.11.001_bib208","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00007890-200009270-00006","article-title":"Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients","volume":"70","author":"Montgomery","year":"2000","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.transci.2005.11.001_bib209","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/01.TP.0000090868.88895.E0","article-title":"Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients","volume":"76","author":"Zachary","year":"2003","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.transci.2005.11.001_bib210","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1515\/CCLM.2000.185","article-title":"Impact of Ig-Therasorb immunoapheresis on stability of xenogeneic ex vivo porcine liver perfusion\u2014value of aminotransferases and flow rates for the assessment of metabolic graft viability","volume":"38","author":"Kornberg","year":"2000","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib211","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0966-3274(01)00047-8","article-title":"Evidence for polyreactive xenoreactive antibodies in the repertoire of human anti-swine antibodies: the \u2018next\u2019 humoral barrier to xenotransplantation?","volume":"9","author":"Gaca","year":"2001","journal-title":"Transpl Immunol"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib212","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0966-3274(01)00047-8","article-title":"Evidence for polyreactive antibodies in the repertoire of human anti-swine antibodies: the \u2018next\u2019 humoral barrier to xenotransplantation?","volume":"9","author":"Gaca","year":"2001","journal-title":"Transpl Immunol"},{"issue":"9","key":"10.1016\/j.transci.2005.11.001_bib213","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1046\/j.1537-2995.2002.00193.x","article-title":"Durable response to combination therapy including staphylococcal protein A immunoadsorption in life-threatening refractory autoimmune hemolysis","volume":"42","author":"Javeed","year":"2002","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.transci.2005.11.001_bib214","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0387-7604(01)00256-X","article-title":"Plasmapheresis in fulminant acute disseminated encephalomyelitis","volume":"23","author":"Miyazawa","year":"2001","journal-title":"Brain Dev"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib215","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000066343","article-title":"Immunoadsorption and plasma exchange in pregnancy","volume":"25","author":"Dittrich","year":"2002","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.transci.2005.11.001_bib216","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2133.2000.03686.x","article-title":"Severe exacerbation of pemphigus vulgaris in pregnancy: successful treatment with plasma exchange","volume":"143","author":"Piontek","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.transci.2005.11.001_bib217","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/(SICI)1098-1101(1996)11:1<30::AID-JCA7>3.0.CO;2-C","article-title":"High avidity anti-DNA antibody removal from the serum of systemic lupus erythematosus patients by adsorption using dextran sulfate cellulose columns","volume":"11","author":"Matsuki","year":"1996","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.transci.2005.11.001_bib218","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1098-1101(1996)11:1<16::AID-JCA4>3.0.CO;2-E","article-title":"Anti-DNA antibody kinetics following selective removal by adsorption using dextran sulfate cellulose columns in patients with systemic lupus erythematosus","volume":"11","author":"Suzuki","year":"1996","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.transci.2005.11.001_bib219","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/jaut.1998.0229","article-title":"Prospective randomized trial of two different immunadsorbers in severe systemic lupus erythematosus","volume":"11","author":"Gaubitz","year":"1998","journal-title":"J Autoimm"},{"issue":"6","key":"10.1016\/j.transci.2005.11.001_bib220","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1526-0968.2002.00408.x","article-title":"Dextran sulfate plasma apheresis improves vascular changes in systemic lupus erythematosus","volume":"6","author":"Braun","year":"2002","journal-title":"Ther Apher"},{"issue":"10","key":"10.1016\/j.transci.2005.11.001_bib221","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/1529-0131(199910)42:10<2153::AID-ANR16>3.0.CO;2-W","article-title":"The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double-blind, sham-controlled trial","volume":"42","author":"Felson","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.transci.2005.11.001_bib222","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/00007890-200212270-00016","article-title":"Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: system, modifications and clinical impact","volume":"74","author":"Millis","year":"2002","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.transci.2005.11.001_bib223","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1525-1594.2002.06931_1.x","article-title":"Modular extracorporeal liver support","volume":"26","author":"Sauer","year":"2002","journal-title":"Artif Organs"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib224","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1034\/j.1399-3089.2002.01076.x","article-title":"Extracorporeal liver perfusion as hepatic assist in acute liver failure: a review of world experience","volume":"9","author":"Pascher","year":"2002","journal-title":"Xenotransplantation"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib225","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00007890-200201270-00019","article-title":"Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation","volume":"73","author":"Samuel","year":"2002","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.transci.2005.11.001_bib226","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/01.TP.0000065018.51103.0C","article-title":"Bioartificial liver: present and future","volume":"75","author":"Samuel","year":"2003","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib227","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/01.TP.0000083319.36931.32","article-title":"Use of primary human liver cells originating from discarded grafts in a bioreactor for liver support therapy and the prospects of culturing adult liver stem cells in bioreactors: a morphologic study","volume":"76","author":"Gerlach","year":"2003","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.transci.2005.11.001_bib228","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1046\/j.1525-1594.2003.07074.x","article-title":"Convective flow through a hollow fiber bioartificial liver","volume":"27","author":"Moussy","year":"2003","journal-title":"Artif Organs"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib229","first-page":"18","article-title":"Bioartificial liver assist devices in support of patients with liver failure","volume":"1","author":"Patzer","year":"2002","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib230","first-page":"649","article-title":"Bioartificial liver support. Review and personal experience","volume":"58","author":"Ambrosino","year":"2003","journal-title":"Minerva Chir"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib231","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1034\/j.1399-3089.2003.00071.x","article-title":"Extracorporal liver perfusion as hepatic assist in acute liver failure: a review of world experience","volume":"10","author":"Bruzzone","year":"2003","journal-title":"Xenotransplantation"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib232","first-page":"401","article-title":"Bioartificial liver with whole blood perfusion","volume":"49","author":"Ueda","year":"2003","journal-title":"ASAIO J"},{"issue":"6","key":"10.1016\/j.transci.2005.11.001_bib233","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1248\/bpb.25.695","article-title":"Practical aspects of the ligand-binding and enzymatic properties of human serum albumin","volume":"25","author":"Kragh-Hansen","year":"2002","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib234","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1034\/j.1399-3046.2002.02007.x","article-title":"Application of MARS artificial liver support as bridging therapy before split liver retransplantation in a 15-month-old child","volume":"6","author":"Hommann","year":"2002","journal-title":"Pediatr Transplant"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib235","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0041-1345(03)00086-1","article-title":"Treatment with the molecular adsorbent recirculating system in patients with acute liver failure","volume":"35","author":"Felldin","year":"2003","journal-title":"Transplant Proc"},{"issue":"Suppl 3","key":"10.1016\/j.transci.2005.11.001_bib236","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1034\/j.1478-3231.23.s.3.8.x","article-title":"Extracorporeal albumin dialysis in patients with Amanita phalloides poisoning","volume":"23","author":"Faybik","year":"2003","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.transci.2005.11.001_bib237","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/lt.500090918","article-title":"Use of molecular adsorbent recirculating system for treatment of refractory pruritus","volume":"9","author":"De Simone","year":"2003","journal-title":"Liver Transpl"},{"issue":"Suppl 2","key":"10.1016\/j.transci.2005.11.001_bib238","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1034\/j.1600-0676.2002.00013.x","article-title":"Emerging indications for MARS dialysis","volume":"22","author":"Schachschal","year":"2002","journal-title":"Liver"},{"key":"10.1016\/j.transci.2005.11.001_bib239","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1525-1594.2002.06822.x","article-title":"The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers","volume":"26","author":"Stange","year":"2002","journal-title":"Artif Organs"},{"issue":"12","key":"10.1016\/j.transci.2005.11.001_bib240","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1097\/00003246-199812000-00001","article-title":"The sirens\u2019 songs of confirmatory sepsis trials: selection bias and sampling error","volume":"26","author":"Natanson","year":"1998","journal-title":"Crit Care Med"},{"issue":"Suppl 1","key":"10.1016\/j.transci.2005.11.001_bib241","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1007\/s001340051121","article-title":"The epidemiology of the systemic inflammatory response","volume":"26","author":"Brun-Buisson","year":"2000","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1016\/j.transci.2005.11.001_bib242","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/jama.1995.03530120060042","article-title":"Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multi center prospective study in intensive care units. French ICU Group for Severe Sepsis","volume":"274","author":"Brun-Buisson","year":"1995","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib243","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s004230050090","article-title":"Outcome of patients with sepsis and septic shock after ICU treatment","volume":"383","author":"Schoenberg","year":"1998","journal-title":"Langenbecks Arch Surg"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib244","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/cc1506","article-title":"The International Sepsis Forum\u2019s controversies in sepsis: how will sepsis be treated in 2051?","volume":"6","author":"Abraham","year":"2002","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib245","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00134-003-1662-x","article-title":"International sepsis definitions conference. 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference","volume":"29","author":"Levy","year":"2003","journal-title":"Intensive Care Med"},{"issue":"13","key":"10.1016\/j.transci.2005.11.001_bib246","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMsb020574","article-title":"Risks and benefits of activated protein C treatment for severe sepsis","volume":"347","author":"Warren","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib247","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1036-7314(05)80036-0","article-title":"The use of activated protein C (drotrecogin alfa (activated)) in the treatment of severe sepsis","volume":"16","author":"Murgo","year":"2003","journal-title":"Aust Crit Care"},{"issue":"6","key":"10.1016\/j.transci.2005.11.001_bib248","first-page":"468","article-title":"CAGS Evidence Based Reviews in Surgery Group (Canadian Association of General Surgeons Evidence Based Reviews in Surgery). 8. Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"46","author":"Barkun","year":"2003","journal-title":"Can J Surg"},{"issue":"12","key":"10.1016\/j.transci.2005.11.001_bib249","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1111\/j.1538-7836.2003.00542.x","article-title":"A definite role for treatment with activated protein C in sepsis? Yes","volume":"1","author":"Weil","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"12","key":"10.1016\/j.transci.2005.11.001_bib250","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1111\/j.1538-7836.2003.00486.x","article-title":"A definite role for treatment with activated protein C in sepsis? Standard use is premature","volume":"1","author":"Girbes","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"1 Suppl","key":"10.1016\/j.transci.2005.11.001_bib251","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1097\/00003246-200301001-00013","article-title":"Recombinant human activated protein C in sepsis: inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials","volume":"31","author":"Eichacker","year":"2003","journal-title":"Crit Care Med"},{"issue":"1 Pt 1","key":"10.1016\/j.transci.2005.11.001_bib252","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1542\/peds.113.1.7","article-title":"Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis","volume":"113","author":"Barton","year":"2004","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib253","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0891-5520(05)70080-5","article-title":"Antiendotoxin strategies","volume":"13","author":"Hellman","year":"1999","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.transci.2005.11.001_bib254","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000060105","article-title":"Extracorporeal blood purification therapy for sepsis and systemic inflammation: its biological rationale","volume":"132","author":"Bellomo","year":"2001","journal-title":"Contrib Nephrol"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib255","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/cc1889","article-title":"Clinical review: extracorporeal blood purification in severe sepsis","volume":"7","author":"Venkataraman","year":"2003","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib256","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1525-1594.2003.00963.x","article-title":"Artificial organ treatment for multiple organ failure, acute renal failure, and sepsis: recent new trends","volume":"27","author":"Tetta","year":"2003","journal-title":"Artif Organs"},{"issue":"84","key":"10.1016\/j.transci.2005.11.001_bib257","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1046\/j.1523-1755.63.s84.40.x","article-title":"Do circulating cytokines really matter in sepsis?","author":"Tetta","year":"2003","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib258","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00130478-200301000-00002","article-title":"The use of extracorporeal techniques to remove humoral factors in sepsis","volume":"4","author":"McMaster","year":"2003","journal-title":"Pediatr Crit Care Med"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib259","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1442-2042.1998.tb00273.x","article-title":"Successful treatment with polymyxin B immobilized fiber of septic shock complicated by renal stone","volume":"5","author":"Soda","year":"1998","journal-title":"Int J Urol"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib260","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1681\/ASN.V104846","article-title":"Cytokine removal during continuous hemofiltration in septic patients","volume":"10","author":"De Vriese","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib261","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s001340050330","article-title":"Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration","volume":"23","author":"Heering","year":"1997","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib262","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/00005373-199905000-00020","article-title":"Effects of long-term hemofiltration on circulating mediators and superoxide production during continuous endotoxin administration","volume":"46","author":"Ishihara","year":"1999","journal-title":"J Trauma"},{"issue":"Suppl 2","key":"10.1016\/j.transci.2005.11.001_bib263","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1755-6686.2002.tb00249.x","article-title":"Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role for CVVH","author":"Ronco","year":"2002","journal-title":"EDTNA ERCA J"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib264","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1034\/j.1399-6576.2002.460203.x","article-title":"Effect of hemodiafiltration and sepsis on chemotaxis of granulocytes and the release of IL-8 and IL-10","volume":"46","author":"Toft","year":"2002","journal-title":"Acta Anaesthesiol Scand"},{"issue":"7","key":"10.1016\/j.transci.2005.11.001_bib265","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/ndt\/gfg115","article-title":"Neumayer HH. TNF-alpha elimination with high cut-off haemofilters: a feasible clinical modality for septic patients?","volume":"18","author":"Morgera","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib266","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1525-1594.1998.06011.x","article-title":"HELP apheresis in the treatment of sepsis","volume":"22","author":"Samtleben","year":"1998","journal-title":"Artif Organs"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib267","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/039139889902200310","article-title":"Push\u2013pull sorbent-based pheresis treatment in an experimental canine endotoxemia model: preliminary report","volume":"22","author":"Peter","year":"1999","journal-title":"Int J Artif Organs"},{"issue":"6","key":"10.1016\/j.transci.2005.11.001_bib268","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1526-0968.2001.00298.x","article-title":"Treatment of systemic inflammatory response syndrome by push\u2013pull powdered sorbent pheresis: a phase 1 clinica trial","volume":"5","author":"Ash","year":"2001","journal-title":"Ther Apher"},{"key":"10.1016\/j.transci.2005.11.001_bib269","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/978-1-4757-5140-6_60","article-title":"New therapeutic method against septic shock\u2014removal of endotoxin using extra corporeal circulation","volume":"256","author":"Kodama","year":"1990","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib270","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0002-9610(94)90126-0","article-title":"Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber","volume":"167","author":"Aoki","year":"1994","journal-title":"Am J Surg"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib271","doi-asserted-by":"crossref","first-page":"M908","DOI":"10.1097\/00002480-199609000-00126","article-title":"Extracorporeal removal of proinflammatory cytokines by specific absorption onto microspheres","volume":"42","author":"Weber","year":"1996","journal-title":"ASAIO J"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib272","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1744-9987.1997.tb00017.x","article-title":"Extracorporeal adsorption of endotoxin","volume":"1","author":"Staubach","year":"1997","journal-title":"Ther Apher"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib273","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1473-0502(03)00100-9","article-title":"A new endotoxin adsorption device in gram negative sepsis of immobilized albumin with the MATISSE adsorber","volume":"29","author":"Staubach","year":"2003","journal-title":"Transfus Apher Sci"},{"issue":"5 Suppl 4","key":"10.1016\/j.transci.2005.11.001_bib274","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/S0272-6386(97)90542-4","article-title":"Extracorporeal adsorbent-based strategies in sepsis","volume":"30","author":"Jaber","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib275","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1744-9987.1998.tb00066.x","article-title":"Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application","volume":"2","author":"Shoji","year":"1998","journal-title":"Ther Apher"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib276","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1526-0968.2003.00005.x","article-title":"Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin)","volume":"7","author":"Shoji","year":"2003","journal-title":"Therap Apher Dial"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib277","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1515\/CCLM.1999.062","article-title":"Endotoxin adsorbent based on immobilized human serum albumin","volume":"37","author":"Zimmermann","year":"1999","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib278","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1526-0968.2002.00449.x","article-title":"Extracorporeal treatment for septic patients: new adsorption technologies and their clinical application","volume":"6","author":"Hanasawa","year":"2002","journal-title":"Ther Apher"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib279","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s001340051200","article-title":"Plasmapheresis combined with continuous venovenous hemofiltration in surgical patients with sepsis","volume":"26","author":"Schmidt","year":"2000","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.transci.2005.11.001_bib280","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1159\/000073444","article-title":"Coupled plasma filtration adsorption: rationale, technical development and early clinical experience","volume":"21","author":"Ronco","year":"2003","journal-title":"Blood Purif"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib281","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00134-003-1724-0","article-title":"Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock","volume":"29","author":"Formica","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.transci.2005.11.001_bib282","unstructured":"Handschel D. Konzeption und Initiierung einer Pilotstudie zur Untersuchung des Stellenwertes der Plasmaaustauschbehandlung als therapeutische Erg\u00e4nzung des fr\u00fchen septischen Schocks. Thesis, University of Cologne, 1999."},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib283","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1046\/j.0007-1048.2002.03353.x","article-title":"Plasma exchange as a source of protein C for acute onset of protein C pathway failure","volume":"116","author":"Hodgson","year":"2002","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.transci.2005.11.001_bib284","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00134-002-1410-7","article-title":"Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial","volume":"28","author":"Busund","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.transci.2005.11.001_bib285","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1097\/01.CCM.0000064742.00981.14","article-title":"Plasma exchange as rescue therapy in multiple organ failure including acute renal failure","volume":"31","author":"Stegmayr","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.transci.2005.11.001_bib286","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(81)91213-7","article-title":"Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia","volume":"II","author":"Stoffel","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2005.11.001_bib287","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1749-6632.1994.tb17328.x","article-title":"Genetic architecture of the atherogenic lipoprotein(a)","volume":"748","author":"Utermann","year":"1995","journal-title":"Ann NY Acad Sci"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib288","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1399-0004.1997.tb04352.x","article-title":"Metabolism of Lp(a): assembly and excretion","volume":"52","author":"Kostner","year":"1997","journal-title":"Clin Genet"},{"issue":"8","key":"10.1016\/j.transci.2005.11.001_bib289","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/hmg\/10.8.815","article-title":"Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6 to 10 domain affect Lp(a) plasma concentrations and have different patterns in Africans and Caucasians","volume":"10","author":"Ogorelkova","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.transci.2005.11.001_bib290","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/10408369609080056","article-title":"Lipoprotein(a) in health and disease","volume":"33","author":"Kronenberg","year":"1996","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"11","key":"10.1016\/j.transci.2005.11.001_bib291","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.CIR.100.11.1154","article-title":"Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study","volume":"100","author":"Kronenberg","year":"1999","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib292","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/01.ATV.20.2.522","article-title":"Lipoprotein(a) in homozygous familial hypercholesterolemia","volume":"20","author":"Kraft","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib293","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1358\/dnp.2002.15.2.668328","article-title":"The physiological role of lipoprotein (a","volume":"15","author":"Kostner","year":"2002","journal-title":"Drug News Perspect"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib294","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00041433-200208000-00006","article-title":"Lipoprotein(a): still an enigma?","volume":"13","author":"Kostner","year":"2002","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib295","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1055\/s-0037-1615178","article-title":"Plasma Lp(a) levels are increased in patients with chronic thromboembolic pulmonary hypertension","volume":"80","author":"Ignatescu","year":"1998","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib296","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1023\/A:1008983110941","article-title":"Plasmin activation system in restenosis: role in pathogenesis and clinical prediction?","volume":"7","author":"Christ","year":"1999","journal-title":"J Thromb Thrombolysis"},{"issue":"10","key":"10.1016\/j.transci.2005.11.001_bib297","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1182\/blood.V98.10.2980","article-title":"Lipoprotein(a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis","volume":"98","author":"Caplice","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib298","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood.V97.4.981","article-title":"Lipoprotein(a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes","volume":"97","author":"Buechler","year":"2001","journal-title":"Blood"},{"issue":"29","key":"10.1016\/j.transci.2005.11.001_bib299","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.2174\/1381612033453820","article-title":"The effects of lipid-regulating therapy on haemostatic parameters","volume":"9","author":"Milionis","year":"2003","journal-title":"Curr Pharm Des"},{"issue":"8","key":"10.1016\/j.transci.2005.11.001_bib300","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.amjmed.2003.06.005","article-title":"Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism","volume":"115","author":"Marcucci","year":"2003","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib301","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.ATV.8.4.398","article-title":"Lipoprotein Lp(a). A rsik factor for myocardial infarction","volume":"8","author":"Hoefler","year":"1988","journal-title":"Arteriosclerosis"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib302","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/clinchem\/36.1.20","article-title":"Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age","volume":"36","author":"Sandkamp","year":"1990","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.transci.2005.11.001_bib303","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/jcp.46.3.267","article-title":"Lipoprotein(a) as an independent risk factor for myocardial infarction in patients with common hypercholesteroaemia","volume":"46","author":"Watts","year":"1993","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib304","first-page":"1132","article-title":"Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study","volume":"32","author":"Cantin","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib305","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1399-0004.1997.tb04344.x","article-title":"Lp(a) lipoprotein is a major risk factor for cardiovascular disease: pathogenic mechanisms and clinical significance","volume":"562","author":"Dahlen","year":"1997","journal-title":"Clin Genet"},{"issue":"7","key":"10.1016\/j.transci.2005.11.001_bib306","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/jama.1996.03540070040028","article-title":"Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study","volume":"276","author":"Bostom","year":"1996","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib307","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1253\/jcj.64.51","article-title":"Lipoprotein(a) is a potential coronary risk factor","volume":"64","author":"Fujino","year":"2000","journal-title":"Jpn Circ J"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib308","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0021-9150(98)00174-9","article-title":"Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study","volume":"141","author":"Hopkins","year":"1998","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib309","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.ejhg.5200152","article-title":"Concentrations of the atherogenic Lp(a) are elevated in FH","volume":"6","author":"Lingenhel","year":"1998","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib310","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF02912466","article-title":"Apolipoproteins and lipoprotein particles in Moroccan patients with previous myocardial infarction","volume":"27","author":"Adlouni","year":"1997","journal-title":"Int J Clin Lab Res"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib311","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0735-1097(00)01126-8","article-title":"Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk","volume":"37","author":"Von Eckardstein","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib312","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0021-9150(00)00719-X","article-title":"Lipoprotein(a) and development of intermittent claudication and major cardiovascular events in men and Women: The Edinburgh Artery Study","volume":"157","author":"Price","year":"2001","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.transci.2005.11.001_bib313","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0002-9149(01)02336-0","article-title":"Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study)","volume":"89","author":"Cantin","year":"2002","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib314","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1681\/ASN.V61110","article-title":"Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis","volume":"6","author":"Kronenberg","year":"1995","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(96)90026-8","article-title":"Lipoprotein(a) in renal disease","volume":"27","author":"Kronenberg","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.transci.2005.11.001_bib316","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0022-2275(20)37150-9","article-title":"Renovascular arteriovenous differences in Lp[a] plasma concentrations suggest removal of Lp[a] from the renal circulation","volume":"38","author":"Kronenberg","year":"1997","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib317","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1399-0004.1997.tb04357.x","article-title":"LDL-unbound apolipoprotein(a) and carotid atherosclerosis in hemodialysis patients","volume":"52","author":"Kronenberg","year":"1997","journal-title":"Clin Genet"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib318","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2362.1997.00108.x","article-title":"LDL-apheresis significantly reduces urinary apo(a) excretion","volume":"27","author":"Kostner","year":"1997","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"10.1016\/j.transci.2005.11.001_bib319","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1365-2362.1998.00319.x","article-title":"Decreased urinary apolipoprotein(a) excretion in patients with impaired renal function","volume":"28","author":"Kostner","year":"1998","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib320","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0021-9150(99)00014-3","article-title":"Lipoprotein(a) plasma concentrations after renal transplantation: a prospective evaluation after 4 years of follow-up","volume":"144","author":"Kerschdorfer","year":"1999","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.transci.2005.11.001_bib321","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/ndt\/gfg181","article-title":"Relationship of non-LDL-bound apo(a), urinary apo(a) fragments and plasma Lp(a) in patients with impaired renal function","volume":"18","author":"Cauza","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"21","key":"10.1016\/j.transci.2005.11.001_bib322","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.1997.03540450045033","article-title":"Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension","volume":"277","author":"Sechi","year":"1997","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.transci.2005.11.001_bib323","first-page":"1013","article-title":"Lipoprotein(a) concentration and apolipoprotein(a) phenotype in subjects with type 2 diabetes mellitus","volume":"111","author":"Shi","year":"1998","journal-title":"Chin Med J"},{"issue":"8","key":"10.1016\/j.transci.2005.11.001_bib324","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s001250051263","article-title":"Is apolipoprotein(a) a susceptibility gene for type I diabetes mellitus and related to long-term survival?","volume":"42","author":"Kronenberg","year":"1999","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.transci.2005.11.001_bib325","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0009-9120(03)00065-1","article-title":"Apoprotein(a) phenotypes and plasma lipoprotein(a) concentration in patients with diabetes mellitus","volume":"36","author":"Labudovic","year":"2003","journal-title":"Clin Biochem"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib326","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0404.1996.tb07042.x","article-title":"Case\u2013control study of serum lipoprotein(a) and apolipoproteins A-I and B in stroke in the young","volume":"94","author":"Christopher","year":"1996","journal-title":"Acta Neurol Scan"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib327","first-page":"397","article-title":"Lipoprotein(a) and cerebral infarction in young adults","volume":"24","author":"Cao","year":"2003","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib328","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1067\/mva.2002.124371","article-title":"Lipoprotein(a) in patients with aortic aneurysmal disease","volume":"36","author":"Schillinger","year":"2002","journal-title":"J Vasc Surg"},{"issue":"5","key":"10.1016\/j.transci.2005.11.001_bib329","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1399-0004.1997.tb04359.x","article-title":"Standardization of Lp(a) measurements","volume":"52","author":"Kostner","year":"1997","journal-title":"Clin Genet"},{"issue":"12","key":"10.1016\/j.transci.2005.11.001_bib330","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0022-2275(20)32100-3","article-title":"Preparation of a stable fresh frozen primary lipoprotein[a] (Lp[a]) standard","volume":"40","author":"Kostner","year":"1999","journal-title":"J Lipid Res"},{"issue":"8 Pt 1","key":"10.1016\/j.transci.2005.11.001_bib331","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/clinchem\/44.8.1629","article-title":"International Federation of Clinical Chemistry standardization project for the measurement of lipoprotein(a). Phase I. Evaluation of the analytical performance of lipoprotein(a) assay systems and commercial calibrators","volume":"44","author":"Tate","year":"1998","journal-title":"Clin Chem"},{"issue":"10","key":"10.1016\/j.transci.2005.11.001_bib332","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1515\/CCLM.1999.140","article-title":"International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Standardization Project for the Measurement of Lipoprotein(a). Phase 2. Selection and properties of a proposed secondary reference material for lipoprotein(a)","volume":"37","author":"Tate","year":"1999","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib333","first-page":"374","article-title":"Lipoprotein(a) determination and risk of cardiovascular disease in South African patients with familial hypercholesterolaemia","volume":"90","author":"Scholtz","year":"2000","journal-title":"S Afr Med J"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib334","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1525-1594.1991.tb00771.x","article-title":"Immunosorbent for selective removal of lipoprotein(a) from human plasma: in vitro study","volume":"15","author":"Pokrovsky","year":"1991","journal-title":"Artif Organs"},{"key":"10.1016\/j.transci.2005.11.001_bib335","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0009-3084(94)90153-8","article-title":"Extracorporeal immunoadsorption for the specific removal of lipoprotein(a) (Lp(a) apheresis): preliminary clinical data","volume":"67\u201368","author":"Pokrovsky","year":"1994","journal-title":"Chem Phys Lipids"},{"issue":"4","key":"10.1016\/j.transci.2005.11.001_bib336","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-5223(03)00365-9","article-title":"Association of lipoprotein(a) excess with early vein graft occlusions in middle-aged men undergoing coronary artery bypass surgery","volume":"126","author":"Pokrovsky","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.transci.2005.11.001_bib337","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0021-9150(02)00026-6","article-title":"PRIME Study Group Lipoprotein(a) as an predictor of coronary heart disease","volume":"163","author":"Luc","year":"2002","journal-title":"The Prime Study Atherosclerosis"},{"issue":"7","key":"10.1016\/j.transci.2005.11.001_bib338","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0002-9149(02)02192-6","article-title":"Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients > or =65 years of age (The Italian Longitudinal Study on Aging, ILSA)","volume":"89","author":"Solfrizzi","year":"2002","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.transci.2005.11.001_bib339","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0002-9343(00)00652-5","article-title":"Lipoprotein(a) as a predictor of myocardial infarction in middle-aged men","volume":"110","author":"Seed","year":"2001","journal-title":"Am J Med"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050205001904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050205001904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T05:52:46Z","timestamp":1706853166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050205001904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":339,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S1473050205001904"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2005.11.001","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}